Preliminary application of virtual reality for pain management in patients undergoing peritoneal dialysis-related procedures
10.3760/cma.j.cn441217-20240123-00132
- VernacularTitle:虚拟现实技术在腹膜透析相关手术术中疼痛管理的应用初探
- Author:
Sixiu CHEN
1
;
Jianbo LI
;
Jianwen YU
;
Yujun ZHOU
;
Youqi LI
;
Xiaojie LIN
;
Naya HUANG
;
Zhong ZHONG
;
Yunuo WANG
;
Jianying LI
;
Qinghua LIU
;
Haiping MAO
;
Fengxian HUANG
;
Wei CHEN
Author Information
1. 中山大学附属第一医院肾内科，卫生健康委肾脏病重点实验室，广东省肾脏病重点实验室，广州510080
- Keywords:
Virtual reality;
Peritoneal dialysis;
Pain;
Patient satisfaction
- From:
Chinese Journal of Nephrology
2024;40(7):520-525
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the application of virtual reality (VR) technology on intraoperative pain in patients undergoing peritoneal dialysis (PD)-related procedures with local infiltration anesthesia and the satisfaction.Methods:It was a single-center, prospective, concurrent controlled study. Patients were divided into two groups: VR group and control group. In the VR group, patients wore a VR headset to watch soothing audio and video content during surgery, while the control group underwent routine procedures. Intraoperative pain and satisfaction were assessed using the visual analog scale (VAS) and a 5-point satisfaction scale within 30 minutes of surgery. In addition, tolerance of the VR experience in the VR group was assessed using the VR sickness questionnaire.Results:A total of 43 patients were included in the study, including 25 males (58.1%). Chronic glomerulonephritis [17 cases (39.5%)] and diabetic nephropathy [6 cases (14.0%)] were the main primary diseases. There were 23 cases in the control group and 20 cases in the VR group. There were no significant differences between the two groups in age, sex ratio, proportion of primary disease, diabetes, hypertension, distribution of operation methods, preoperative vital signs and operation time (all P>0.05). VAS pain score was significantly lower in the VR group than that in the control group (5.90±2.38 vs. 7.43±1.67, t=2.469, P=0.018). The percentage of patients who were satisfied was 89.5% (17/19) in the VR group and 78.3% (18/23) in the control group, but there was no significant difference (chi-square test for continuity correction, χ2=0.308, P=0.579). Three patients in the VR group withdrew from the study due to severe discomfort, while the remaining participants found the VR experience to be tolerable. Common adverse effects included fatigue and blurred vision. Conclusions:The application of VR technology in PD-related procedures has been effective in reducing intraoperative pain when combined with local infiltration anesthesia. Furthermore, the utilization of VR technology in PD-related procedures is associated with a safe and tolerable outcome, despite the observation of some adverse effects.
